Ex-Spectranetics Corporation CEO's Conviction Stands

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

A federal appeals court denies ex-Spectranetics CEO John Schulte's bid to overturn his conviction on a single count of lying to the FBI and declines to revisit the case. Former Spectranetics (NSDQ:SPNC) CEO John Schulte's 2012 conviction on a single count of lying to federal investigators survived his appeal to an appeals court, meaning his sentence of a year's probation will stand. Schulte was convicted in March 2012 for his role in the allegedly illegal importation of medical devices for a clinical trial and sentenced later that year.

Help employers find you! Check out all the jobs and post your resume.

Back to news